Plain-English translation of NCT07750873 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Phase 2 — Testing in a bigger group (up to a few hundred people) to see if the treatment actually works and is still safe.
This trial is testing a new medication called for people with heart failure—a condition where the heart doesn't pump blood as well as it should. Researchers want to see if this medication, taken twice daily for 6 months alongside your regular heart medicines, can safely help improve how your heart works and how you feel.
Heart failure is a serious condition that affects millions of people, and many patients still struggle even with current treatments. This medication targets a specific problem in heart cells, and researchers hope it could offer a new way to help the heart pump more effectively.
You likely qualify if…
You likely don't qualify if…
If you join this trial, you'll take a tablet twice daily—either the new medication at one of three different doses or a placebo (inactive pill)—for 24 weeks while continuing your regular heart medicines. You'll have regular clinic visits where doctors will check your heart health, run blood tests, and monitor how you're doing. About half of the 525 participants will receive the medication and half will receive placebo, decided by chance.
AI-generated summary from trial data · Aug 12, 2026 · Not medical advice
United States